BC
Boxer Capital Portfolio holdings
AUM
$2.04B
1-Year Return
108.35%
This Quarter Return
+18.32%
1 Year Return
+108.35%
3 Year Return
+260.95%
5 Year Return
+1,103.68%
10 Year Return
–
AUM
$400M
AUM Growth
-$23.9M
(-5.6%)
Cap. Flow
-$89.8M
Cap. Flow
% of AUM
-22.42%
Top 10 Holdings %
Top 10 Hldgs %
84.04%
Holding
33
New
3
Increased
4
Reduced
8
Closed
7
Top Buys
Top Sells
| 1 |
CLVS
Clovis Oncology, Inc.
CLVS
|
$46.8M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
$26.4M |
| 3 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$18.8M |
| 4 |
Alnylam Pharmaceuticals
ALNY
|
$12.8M |
| 5 |
Esperion Therapeutics
ESPR
|
$12.7M |
Sector Composition
| 1 | Healthcare | 87.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONTXW
26
DELISTED
Onconova Therapeutics, Inc. Warrants
ONTXW
| $109K | 0.03% |
241,644
| – | – |
|
|
AKTX
27
Akari Therapeutics
AKTX
$26.7M
| – | – |
-4,751
| Closed | -$1.05M |
|
28
Aldeyra Therapeutics
ALDX
$334M
| – | – |
-291,230
| Closed | -$1.46M |
|
|
29
Alnylam Pharmaceuticals
ALNY
$59.2B
| – | – |
-250,000
| Closed | -$12.8M |
|
30
AnaptysBio
ANAB
$613M
| – | – |
-50,000
| Closed | -$1.39M |
|
|
ALXN
31
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| – | – |
-75,000
| Closed | -$9.09M |
|
|
ARDM
32
DELISTED
Aradigm Corp Common Stock
ARDM
| – | – |
-576,208
| Closed | -$893K |
|
|
NVET
33
DELISTED
Nexvet Biopharma plc Ordinary Shares
NVET
| – | – |
-154,840
| Closed | -$602K |
|